Elekta (EKTAY) Stock Price, News & Analysis

Company Overview

Elekta is a Swedish medical technology company that develops equipment and software for radiation therapy and other treatments used in cancer care and neurosurgery. Founded in 1972 by neurosurgeon Lars Leksell, the company builds on his work in stereotactic radiosurgery.

Its offerings include linear accelerators for external-beam radiation therapy, systems for stereotactic radiosurgery and brachytherapy, and software that helps healthcare providers plan and manage treatment. Elekta’s technologies are used by hospitals and clinics to deliver care for cancer and certain neurological conditions.

The company serves healthcare providers in markets around the world. Its work spans equipment, treatment-planning tools, and clinical information systems designed to support radiation oncology services.

Key Stats

• Today's Range: $6.10 to $6.10
• 50-Day Range: $5.02 to $6.23
• 52-Week Range: $4.35 to $6.93
• Volume: 531 shs
• Average Volume: 803 shs
• Market Capitalization: $2.25 billion
• P/E Ratio: N/A
• Dividend Yield: 1.97%
• Price Target: N/A
• Consensus Rating: Hold

Elekta Stock Analysis - MarketRank™

Elekta scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Elekta has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Elekta has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.30%

Earnings Growth

Earnings for Elekta are expected to grow by 9.30% in the coming year, from $0.43 to $0.47 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Elekta is -50.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Elekta is -50.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Elekta has a P/B Ratio of 2.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Elekta has been sold short.

Short Interest Ratio / Days to Cover

Elekta has a short interest ratio ("days to cover") of 0.26, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Elekta pays a meaningful dividend of 2.00%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Elekta does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Elekta will have a dividend payout ratio of 25.53% next year. This indicates that Elekta will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Elekta this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Elekta insiders have not sold or bought any company stock.

Percentage Held by Insiders

41.28% of the stock of Elekta is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Elekta has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/27/2026
• Today: 11/13/2026
• Next Earnings (Estimated): 11/25/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:EKTAY
• CIK: 1451160
• Web: www.elekta.com
• Phone: (685) 872-5400
• Fax: 46-8-587-255-00
• Employees: 4,102
• Year Founded: 1972

Profitability

• EPS (Trailing Twelve Months): ($0.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 12.98
• P/E Growth: N/A
• Net Income: -$55.38 million
• Net Margins: -2.38%
• Pretax Margin: 0.40%
• Return on Equity: 13.47%
• Return on Assets: 3.84%

Debt

• Debt-to-Equity Ratio: 0.45
• Current Ratio: 0.86
• Quick Ratio: 0.62

Sales & Book Value

• Annual Sales: $1.78 billion
• Price / Sales: 1.26
• Cash Flow: $0.62 per share
• Price / Cash Flow: 9.90
• Book Value: $2.07 per share
• Price / Book: 2.95

Miscellaneous

• Outstanding Shares: 368,588,000
• Free Float: 216,435,000
• Market Cap: $2.25 billion
• Optionable: Not Optionable
• Beta: 1.01